Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 14, 2023

Impact of Finerenone-Induced Albuminuria Reduction on CKD Outcomes in Type 2 Diabetes

Annals of Internal Medicine

 

Additional Info

Annals of Internal Medicine
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis
Ann. Intern. Med 2023 Dec 05;[EPub Ahead of Print], R Agarwal, W Tu, AE Farjat, YMK Farag, R Toto, S Kaul, R Lawatscheck, K Rohwedder, LM Ruilope, P Rossing, B Pitt, G Filippatos, SD Anker, GL Bakris

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading